(Q28275074)

2

0 references

W S Tung

3

0 references

O Kisker

4

0 references

S A Wells

5

0 references

P J Goodfellow

Genes, Chromosomes and Cancer

6

0 references

language of work or name

English

0 references

publication date

November 1995

0 references

published in

0 references

volume

14

0 references

issue

3

0 references

page(s)

189-95

0 references

cites work

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Clinical implications of the p53 tumor-suppressor gene

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Report and abstracts of the Second International Workshop on Human Chromosome 9 Mapping 1993

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

p53 mutations: gains or losses?

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Low frequency of CDKN2 mutation in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

P16 gene in uncultured tumours

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870140306

7 January 2021